Dr. Lal PathLabs Ltd. has shown significant price movement.
Recent Performance: The stock increased by 2.51%.
Support and Resistance Levels:
- Support: ₹2898.10
- Resistance: ₹3217.60
Moving Averages:
- 14 EMA: ₹2972.40
- 7 EMA: ₹2991.96
Key Financial Metrics:
- PE Ratio: 53.20
- EPS: ₹57.67
- Market Cap: ₹25,130 Crores
- Recent Earnings: FY 2023-2024 revenue ₹4,200 Crores, with PAT of ₹520 Crores
Entry, Exit, and Stop Loss:
- Entry Point: Above ₹3100 if signs of recovery are shown
- Exit Point: Near ₹3200 (resistance level)
- Stop Loss: At ₹2950
Disclaimer - Not a Buy/Sell Recommendation.
Recent Performance: The stock increased by 2.51%.
Support and Resistance Levels:
- Support: ₹2898.10
- Resistance: ₹3217.60
Moving Averages:
- 14 EMA: ₹2972.40
- 7 EMA: ₹2991.96
Key Financial Metrics:
- PE Ratio: 53.20
- EPS: ₹57.67
- Market Cap: ₹25,130 Crores
- Recent Earnings: FY 2023-2024 revenue ₹4,200 Crores, with PAT of ₹520 Crores
Entry, Exit, and Stop Loss:
- Entry Point: Above ₹3100 if signs of recovery are shown
- Exit Point: Near ₹3200 (resistance level)
- Stop Loss: At ₹2950
Disclaimer - Not a Buy/Sell Recommendation.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.